Forecast for Wed 19 Jun 2024 price 0.42
Kronos Bio, Inc stock price forecast for further price development down to -44.07% (time horizon: 1 day) and price target of 0.67 USD. Short-term (time horizon: 2 weeks) Kronos Bio, Inc share price prediction for 2024-06-19 with daily closed price projections
Forecast price change %
Relative Strength Index (RSI)
Earnings per share -2.73
On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.
We pursue these high-value targets using our differentiated product engine. 8226;Establish clinical proof of concept for our CDK9 program. The FDA cleared our IND for KB-0742 in December 2020. ENTO has also been tested in a Phase 1b/2 clinical trial in 148 AML patients. Dysregulation of the androgen receptor (AR) TRN is a primary driver of prostate cancer. In addition, a product may be eligible for accelerated approval. PMA applications are subject to an application fee. We are not currently a party to any material legal proceedings. Our corporate website address is www.kronosbio.com. We had cash, cash equivalents, and investments of $462.1 million as of December 31, 2020. A failure of one or more clinical trials can occur at any stage of testing. As a result, the coverage determination process is often time-consuming and costly. The development and commercialization of pharmaceutical products is highly competitive. We generally contract with third parties for the disposal of these materials and wastes. We may fail to obtain any of these licenses on commercially reasonable terms, if at all. In addition, there is a natural transition period when a new CRO commences work. We expect to rely on third parties for the manufacture of our product candidates. As of January 1, 2021, we had 63 full-time employees. Therefore, these provisions could adversely affect the price of our common stock. However, we have not opted out of this provision.
Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.
Institutional ownership list is based on filling form information
| Holding name | Date | Amount |
|---|---|---|
| A - BARCLAYS PLC | 2023-06-30 | 16128 |
| A - Coastal Bridge Advisors, LLC | 2023-06-30 | 51968 |
| VOYA INVESTMENT MANAGEMENT LLC | 2022-09-30 | 15094 |
| MetLife Investment Management, LLC | 2022-09-30 | 25568 |
| MetLife Investment Management, LLC | 2022-03-31 | 24534 |
Fund ownership list is based on filling form information
| Fund name | Date | Amount | Profile |
|---|---|---|---|
| BlackRock Funds | 2023-11-30 | 43065 | Long |
| Fidelity Select Portfolios | 2023-11-30 | 365200 | Long |
| Fidelity Concord Street Trust | 2023-11-30 | 53162 | Long |
| Fidelity Concord Street Trust | 2023-11-30 | 77287 | Long |
| Fidelity Concord Street Trust | 2023-11-30 | 20542 | Long |
Insider trading for Kronos Bio, Inc
| CIK | Name | Date | Action | T-Test 1day | T-Test 7day | T-Test 14day | T-Test 30day |
|---|---|---|---|---|---|---|---|
| 1190273 | Bischofberger Norbert W | 2023-11-16 | BUY | Reject | Reject | Reject | Reject |
| 1826766 | Dinsmore Christopher | 2024-01-04 | SALE | Accept | Accept | Accept | Accept |
| 1826732 | Dimartino Jorge | 2024-01-04 | SALE | Accept | Accept | Accept | Accept |
| 1650691 | Al-wakeel Yasir B. | 2023-07-06 | SALE | Accept | Accept | Accept | Accept |
| 1763316 | Kosacz Barbara | 2024-01-04 | SALE | Accept | Accept | Accept | Accept |
Bollinger Bollinger Bands for Kronos Bio, Inc can provide the information where the market is moving based on price information.
Kronos Bio, Inc Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.
Converting prices to returns Kronos Bio, Inc.
On-Balance Volume information for Kronos Bio, Inc. On-Balance Volume information can be an indicator for bullish or bearish outcome.
Accumulation / Distribution (A/D) indicator information for Kronos Bio, Inc. The indicator identify divergences between price and volume flow.
Aroon Oscillator information for Kronos Bio, Inc. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.
Average Directional Index (ADX) information for Kronos Bio, Inc. The index can be used to identify the strengh of a trend.
Moving Average Convergence Divergence (MACD) for Kronos Bio, Inc. The indicator helps to predict trend direction and the momentum of the trend.
Stochastic Oscillator as momentum indicator for Kronos Bio, Inc. The indicator is useful for identifying overbought and oversold levels.
Relative Strength Index (RSI) for Kronos Bio, Inc. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].
Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.
The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.
The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.
Moving Average Crossover
| 52W High | 52W Low | Market Cap |
| Date | Closing price | Prediction was updated |
|---|---|---|
| 2024-05-24 | 0.67 | 2024-04-24 09:04 |
| 2024-05-22 | 0.69 | 2024-04-24 09:04 |
| 2024-05-23 | 0.68 | 2024-04-24 09:04 |
| 2024-05-20 | 0.72 | 2024-04-24 09:04 |
| 2024-05-21 | 0.71 | 2024-04-24 09:04 |
| 2024-06-07 | 0.53 | 2024-04-24 09:04 |
| 2024-06-05 | 0.56 | 2024-04-24 09:04 |
| 2024-05-30 | 0.61 | 2024-04-24 09:04 |
| 2024-05-29 | 0.62 | 2024-04-24 09:04 |
| 2024-06-03 | 0.58 | 2024-04-24 09:04 |
| 2024-06-04 | 0.57 | 2024-04-24 09:04 |
| 2024-05-31 | 0.60 | 2024-04-24 09:04 |
| 2024-05-27 | 0.65 | 2024-04-24 09:04 |
| 2024-05-28 | 0.64 | 2024-04-24 09:04 |
| 2024-06-06 | 0.54 | 2024-04-24 09:04 |
| 2024-06-10 | 0.52 | 2024-04-24 09:04 |
| 2024-06-11 | 0.50 | 2024-04-24 09:04 |
| 2024-06-19 | 0.42 | 2024-04-24 09:04 |
| 2024-06-17 | 0.45 | 2024-04-24 09:04 |
| 2024-06-18 | 0.44 | 2024-04-24 09:04 |
| 2024-06-12 | 0.49 | 2024-04-24 09:04 |
| 2024-06-13 | 0.48 | 2024-04-24 09:04 |
| 2024-06-14 | 0.46 | 2024-04-24 09:04 |
| 2024-05-06 | 0.87 | 2024-04-24 09:04 |
| 2024-05-13 | 0.79 | 2024-04-24 09:04 |
| 2024-05-14 | 0.78 | 2024-04-24 09:04 |
| 2024-05-15 | 0.76 | 2024-04-24 09:04 |
| 2024-05-16 | 0.75 | 2024-04-24 09:04 |
| 2024-04-30 | 0.90 | 2024-04-24 09:04 |
| 2024-05-07 | 0.85 | 2024-04-24 09:04 |
| 2024-05-08 | 0.83 | 2024-04-24 09:04 |
| 2024-05-09 | 0.82 | 2024-04-24 09:04 |
| 2024-05-17 | 0.73 | 2024-04-24 09:04 |
| 2024-04-26 | 0.92 | 2024-04-24 09:04 |
| 2024-04-29 | 0.91 | 2024-04-24 09:04 |
| 2024-05-01 | 0.90 | 2024-04-24 09:04 |
| 2024-05-02 | 0.88 | 2024-04-24 09:04 |
| 2024-05-03 | 0.87 | 2024-04-24 09:04 |
| 2024-05-10 | 0.81 | 2024-04-24 09:04 |
The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.
